TIR is usually applied in continuous glucose monitoring systems (CGMS), indicated in Germany only for patients with T1DM or T2DM on intensified insulin therapy or continuous subcutaneous insulin infusion at risk of severe hypoglycemia [46]. This evidence concerns the gene INS and type 1 diabetes mellitus.